Obesity significantly elevates the risk of conditions such as type 2 diabetes, hypertension and cardiovascular disorders, creating stronger demand for treatments capable of producing sustained weight loss and improving overall metabolic health
An exploratory signal suggested a potential lower risk of heart failure hospitalization with semaglutide compared to dapagliflozin
The product is intended exclusively for scientific research and in vitro applications and is not a medicinal product
SCC will metastasise in approximately 5% of cases, but this risk is higher if the lesion is large or deep, or is located on the ear, lip, genitals or on mucosal surfaces, or involves nerve fibres
Stick to weekly dosing unless your provider specifically prescribes a different schedule
Dose: Take one Capsule Twice Daily With Meals